FDA OKs drug for pain during sex for postmenopausal women

02/26/2013 | CBS News · Drug Store News

Shionogi's Osphena, or ospemifene, has been approved by the FDA to treat dyspareunia, a condition characterized by pain during sex, in postmenopausal women. The drug gives patients another option for treatment, FDA Office of Drug Evaluation Deputy Director Victoria Kusiak said.

View Full Article in:

CBS News · Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC